Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

TB Genotyping

TB genotyping is a laboratory-based approach used to analyze the genetic material (e.g., DNA) of Mycobacterium tuberculosis, the bacterium that cause TB disease. The total genetic content is referred to as the genome. Specific sections of the M. tuberculosis genome form distinct genetic patterns that help distinguish different strains of M. tuberculosis.

Why use TB genotyping?

TB genotyping results, when combined with epidemiologic data, help identify persons with TB disease involved in the same chain of recent transmission. In the same way, TB genotyping helps distinguish between persons whose TB disease is the result of TB infection that was acquired in the past, as compared to recently or newly acquired infection with development of TB disease. TB genotyping is a tool that can add value to conventional contact investigation.

Since TB prevention and control efforts directed at preventing TB transmission are fundamentally different from efforts to prevent activation of latent TB infection, genotyping offers a powerful tool to help direct the application of appropriate efforts. Furthermore, TB genotyping allows us to monitor our progress toward eliminating TB transmission more accurately.

TB Genotyping Information Management System (TB GIMS)

The TB Genotyping Information Management System (TB GIMS) is a secure web-based system designed to improve access and dissemination of genotyping information nationwide. TB GIMS was released in March 2010.